melanoma

University of Missouri, Columbia, US, biomedical engineering and dermatology associate professor John Viator has developed a new medical diagnostic device to speed up the detection of deadly metastatic melanomas.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The melanoma detection device, the size of a typical desktop printer, was the outcome of more than five years of research and development at the university’s Christopher S. Bond Life Sciences Center.

Partially funded by a $33,000 research grant from the American Society for Laser Medicine and Surgery (ASLMS), the new device is expected to be available for use to diagnose and treat melanomas before they get to advanced stages, pending regulatory approval from the US Food and Drug Administration (FDA).

The new photoacoustic melanoma detection device delivers laser light into enriched blood cell samples consisting of millions of white blood cells and possibly cancer cells for the immediate detection of melanoma cells.

Using the new technique, the cell samples are separated into discrete small droplets for scanning and detection of both melanoma and non-melanoma cancer cells. The droplets, which produce photoacoustic waves, contain cancer cells and are separated for further examination.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The new device is expected to ensure early detection of melanomas by spotting circulating tumour cells in the blood.

The American Society for Laser Medicine and Surgery aims to improve patient care by advancing biomedical application of lasers and related technology worldwide.

Image: Melanoma in skin biopsy with H&E stain. Photo: KGH.